Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lockett

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER <sup>-</sup> Breast Tumors that Lead to Poor OutcomeRobert Ys Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Ys Cheng, et al.
Cell Death & Disease|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcomeRobert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Redox Biology|November 14, 2022
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and densityVeena Somasundaram, Lisa A Ridnour, Robert Ys Cheng, et al.
British Journal of Cancer|June 22, 2021
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancerHanna T Sjoberg, Yiannis Philippou, Anette L Magnussen, et al.
JCI Insight|July 15, 2025
Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER- breast cancerLisa A Ridnour, Robert Ys Cheng, William F Heinz, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patientsLisa A Ridnour, Robert Y S Cheng, William F Heinz, et al.
Cancer Research Communications|October 2, 2024
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Y S Cheng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 2, 2020
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individualsPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
JCI Insight|June 24, 2024
Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumorsLisa A Ridnour, Robert Ys Cheng, Noemi Kedei, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER <sup>-</sup> Breast Tumors that Lead to Poor OutcomeRobert Ys Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Ys Cheng, et al.
Cell Death & Disease|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcomeRobert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Redox Biology|November 14, 2022
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and densityVeena Somasundaram, Lisa A Ridnour, Robert Ys Cheng, et al.
British Journal of Cancer|June 22, 2021
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancerHanna T Sjoberg, Yiannis Philippou, Anette L Magnussen, et al.
JCI Insight|July 15, 2025
Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER- breast cancerLisa A Ridnour, Robert Ys Cheng, William F Heinz, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patientsLisa A Ridnour, Robert Y S Cheng, William F Heinz, et al.
Cancer Research Communications|October 2, 2024
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Y S Cheng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 2, 2020
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individualsPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
JCI Insight|June 24, 2024
Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumorsLisa A Ridnour, Robert Ys Cheng, Noemi Kedei, et al.
Pageof 19